Two GlaxoSmithKline investigators have published a method that combines side-effect information from drug labels with drug-disease relationships from publicly available resources to predict possible new uses for these treatments.

The method, dubbed Drug Repositioning based on the Side-Effectome, or DRoSEf, was published in a recent edition of PLoS One.